How is the COWS score interpreted?

5-12: Mild withdrawal (monitor closely; buprenorphine induction typically requires COWS 8-12+). 13-24: Moderate withdrawal (pharmacotherapy indicated). 25-36: Moderately severe withdrawal (medication required). Above 36: Severe withdrawal (indicates high dependence and intensive treatment need). Scores below 5 suggest minimal withdrawal or possible non-opioid cause of symptoms.

What does a moderate COWS score mean for treatment?

A moderate COWS score of 13-24 indicates significant opioid withdrawal with autonomic instability and substantial subjective distress that warrants pharmacotherapy. This range typically confirms adequate withdrawal for standard buprenorphine induction (COWS 13 is well above the 8-12 threshold). Treatment options at this level include buprenorphine induction (preferred for MOUD), methadone dose administration in OTP patients, or clonidine for symptom management when MOUD is not immediately available.

What is methadone versus buprenorphine for opioid use disorder?

Both are FDA-approved medications for opioid use disorder (MOUD). Methadone: full opioid agonist; dispensed daily at licensed opioid treatment programs (OTPs); no precipitated withdrawal risk; highly effective but requires daily clinic visits. Buprenorphine/naloxone (Suboxone): partial agonist with ceiling effect and lower overdose risk; can be prescribed by any DEA-registered provider for take-home use since 2023 X-waiver removal; requires adequate withdrawal (COWS 8+) for induction. Both reduce opioid use, mortality, and HIV/hepatitis C transmission. Choice depends on patient preference, access, and clinical factors.

What is the fentanyl withdrawal timeline?

Fentanyl withdrawal timeline differs from heroin due to its high lipophilicity and extensive tissue binding. Initial withdrawal symptoms may not begin until 24-36 hours after last use (vs 8-16 hours for heroin). Peak withdrawal: 48-96 hours, often later than heroin. Resolution: 1-2 weeks, with protracted symptoms possible. For buprenorphine induction in fentanyl users, many clinicians wait 24-48+ hours after last use, use a higher COWS threshold (12-16), or employ low-dose induction (LDEI) protocols to circumvent precipitated withdrawal risk from residual fentanyl tissue stores.

What medications are used for opioid use disorder?

The three FDA-approved MOUD options are: (1) Buprenorphine/naloxone (Suboxone, Sublocade): partial agonist, low overdose risk, office-based prescribing by any DEA registrant. (2) Methadone: full agonist, highest retention and efficacy, dispensed at OTPs only. (3) Extended-release naltrexone (Vivitrol): opioid antagonist, requires full detox (7+ days off opioids), monthly IM injection, no misuse potential. All three reduce opioid use, overdose mortality, HIV/HCV transmission, and criminal justice involvement. MOUD access is associated with 50%+ reduction in all-cause mortality.

What does COWS below 8 mean?

A COWS score below 8 suggests mild or no significant opioid withdrawal. In this range, the patient likely still has sufficient opioid receptor occupancy that buprenorphine induction would risk precipitated withdrawal. Clinical actions: verify the last dose timing and wait for natural withdrawal progression; reassess every 1-2 hours; do not administer buprenorphine; consider low-dose induction protocols if the patient cannot wait or is using fentanyl. Scores below 5 suggest the patient may not be in opioid withdrawal at all — assess for non-opioid causes of symptoms.

What are the opioid use disorder treatment options beyond MOUD?

Medication is the most effective OUD treatment, but comprehensive care also includes behavioral therapy (contingency management, CBT, motivational interviewing), peer support services (recovery coaches), harm reduction (naloxone distribution, syringe service programs, safer use education), housing and social support, and treatment of co-occurring psychiatric conditions (depression, PTSD, anxiety). MOUD without psychosocial support has lower retention than combined treatment. All patients on MOUD should have naloxone prescribed for overdose reversal in case of relapse.

Online Medical Tools — COWS Score

Printed on 9/3/2026

For informational purposes only. This is not medical advice.

Mental Health

COWS Score

COWS is a structured withdrawal severity tool that combines observed and reported symptoms to classify opioid withdrawal intensity and support treatment planning in supervised settings.

Formula: COWS total = sum of 11 domain scores (range 0-48).

Resting pulse rate

Sweating

Restlessness

Pupil size

Bone or joint aches

Runny nose or tearing

GI upset

Tremor

Yawning

Anxiety or irritability

Gooseflesh skin

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Clinician Assesses 11 Objective and Subjective Withdrawal Items

The COWS combines clinician observation with patient self-report across 11 items covering both autonomic and subjective opioid withdrawal manifestations. Observed items: resting pulse rate, sweating, pupil size, tremor, yawning, and gooseflesh (piloerection). Patient-reported items: restlessness, bone/joint aches, runny nose/tearing, GI upset, and anxiety/irritability. Each item uses a specific scoring range (0-3, 0-4, or 0-5) with anchored descriptors. Pupil dilation is a particularly reliable objective marker — opioid withdrawal causes parasympathetic rebound and marked mydriasis.

Sum All Items to Produce Total Score (0-48)

After assessing all 11 items, sum the individual scores to produce a total between 0 and approximately 48 (maximum varies slightly by version). Reassessment frequency depends on severity and clinical context — typically every 4-8 hours during active withdrawal, and more frequently around the time of planned buprenorphine induction (every 1-2 hours). Document the time of each assessment and any medications given, as COWS scores are used to trigger and titrate treatment interventions.

Interpret Score to Guide Treatment — Especially Buprenorphine Induction Timing

Mild withdrawal (COWS 5-12): patient is in early withdrawal — monitor closely; buprenorphine induction may proceed at COWS 8-12. Moderate withdrawal (COWS 13-24): pharmacotherapy indicated; buprenorphine induction typically safe. Moderately severe withdrawal (COWS 25-36): medication required. Severe withdrawal (COWS above 36): indicates severe dependence and high medication need. Critical rule: do not administer buprenorphine if COWS is below 8, as precipitated withdrawal can occur when the patient has significant residual opioids occupying receptors.

Who Uses the COWS Score

Opioid Detoxification Inpatient Monitoring

Addiction Medicine Specialists

COWS is the standard monitoring tool for opioid withdrawal in inpatient detoxification settings. Serial COWS assessments track symptom trajectory, guide alpha-2 agonist (clonidine) or opioid agonist dosing, and determine discharge readiness based on symptom resolution.

Buprenorphine Induction Timing Assessment

Buprenorphine Prescribers

The most critical application of COWS is determining when it is safe to administer the first dose of buprenorphine. A COWS score of 8-12 or above is typically required before induction to avoid precipitated withdrawal from buprenorphine displacing full opioid agonists.

Methadone Clinic Opioid Withdrawal Monitoring

Methadone Counselors

Opioid treatment programs (OTPs) use COWS to assess withdrawal severity in patients during observed dosing, to document adequate withdrawal before first methadone dose, and to monitor patients during dose adjustments or interruptions in methadone access.

Emergency Department Opioid Withdrawal Management

Emergency Physicians

Emergency departments increasingly initiate buprenorphine for patients presenting in opioid withdrawal. COWS provides the objective documentation of withdrawal severity needed to justify buprenorphine induction in the ED and creates a baseline for outpatient MOUD continuation.

Opioid Use Disorder Research Endpoint

Researchers

The COWS is used as a standardized outcome measure in opioid use disorder clinical trials to quantify withdrawal severity during detoxification and to document successful buprenorphine or methadone induction. Its 0-48 continuous scale enables quantitative between-group comparisons.

Suboxone Initiation in MOUD Programs

MOUD Providers

Medications for opioid use disorder (MOUD) programs use COWS to assess readiness for buprenorphine/naloxone (Suboxone) induction, guiding the timing of first dosing and documenting clinical necessity for insurance authorization and regulatory compliance.

Pro Tips

Buprenorphine Induction Requires COWS 8-12 Minimum to Avoid Precipitated Withdrawal

Buprenorphine is a partial opioid agonist with very high mu-receptor affinity. When administered to a patient who still has significant full opioid agonists (heroin, oxycodone, methadone) occupying receptors without being in withdrawal, buprenorphine rapidly displaces them, causing an immediate, severe withdrawal syndrome (precipitated withdrawal). To prevent this, the patient must be in objective withdrawal — COWS 8-12 or above — before the first buprenorphine dose. Always confirm that COWS is at threshold before administering the first dose.

Precipitated Withdrawal From Buprenorphine Is Severe and Distressing

Precipitated opioid withdrawal from premature buprenorphine induction is characterized by sudden, intense, all-body withdrawal symptoms — severe muscle aches, restlessness, diaphoresis, nausea, vomiting, and extreme dysphoria — that begin within minutes of buprenorphine dosing and can last several hours. Unlike gradual spontaneous withdrawal, precipitated withdrawal onset is abrupt and the severity peaks rapidly. It is not life-threatening but is extremely distressing and can severely damage patient trust and willingness to continue MOUD. Prevention by ensuring adequate COWS score before induction is essential.

Do Not Give Buprenorphine If COWS Is Below 8 — Wait for Adequate Withdrawal

If a patient presents requesting buprenorphine but their COWS score is below 8, do not administer the first dose. Educate the patient about why waiting is important, reassess every 1-2 hours, and initiate when COWS reaches threshold. In urgent situations where the patient cannot wait, consider low-dose buprenorphine induction (micro-dosing/LDEI) protocols that circumvent the need for full withdrawal onset.

Fentanyl Complicates Buprenorphine Induction Due to Prolonged Tissue Storage

The dominance of illicit fentanyl in the opioid supply has significantly complicated buprenorphine induction. Fentanyl is highly lipophilic and accumulates in body fat, resulting in prolonged tissue binding and slow release that can make patients appear to have lower COWS scores than their actual receptor occupancy warrants. Patients using fentanyl may need a COWS score of 12-16 or above before induction is safe, or may benefit from extended waiting periods (24-48 hours or longer) or low-dose induction protocols.

Low-Dose Buprenorphine Induction (LDEI/Micro-Dosing) Circumvents Precipitated Withdrawal Risk

The low-dose buprenorphine induction (LDEI) protocol, also called 'micro-dosing' or the Bernese method, administers very small doses of buprenorphine (0.5-2mg) daily while the patient is still on full opioid agonists, gradually increasing the dose over 5-7 days until full buprenorphine doses can be given. This approach avoids precipitated withdrawal and is particularly valuable for patients on methadone or high-dose fentanyl where standard induction timelines are impractical.

DEA X-Waiver Removed in 2023 — Any DEA-Registered Provider Can Prescribe Buprenorphine

The Mainstreaming Addiction Treatment (MAT) Act, included in the Consolidated Appropriations Act of 2023, eliminated the requirement for a special DEA X-waiver (DATA 2000) to prescribe buprenorphine for opioid use disorder. Any DEA-registered healthcare provider can now prescribe buprenorphine/naloxone (Suboxone) in an office-based setting. This removes a major barrier to expanding MOUD access. Emergency physicians, hospitalists, and primary care providers are now empowered to initiate buprenorphine without special certification.

Methadone Requires Daily Supervised Dosing at Licensed Opioid Treatment Programs

Methadone for opioid use disorder must be dispensed daily in federally licensed opioid treatment programs (OTPs). Unlike buprenorphine, which can be prescribed by any DEA-registered provider for take-home use, methadone for OUD has strict federal regulatory requirements. COWS monitoring is used in OTPs to assess patient withdrawal status, guide initial dose, and monitor clinical status during dose adjustments. Extended-release naltrexone (Vivitrol) is a third MOUD option requiring full opioid detoxification (7+ days off all opioids) before initiation.

Clonidine Reduces Autonomic Withdrawal Symptoms But Is Not an OUD Treatment

Alpha-2 agonists like clonidine are frequently used to reduce autonomic opioid withdrawal symptoms (diaphoresis, elevated pulse, hypertension, restlessness) captured by COWS items. Clonidine is not FDA-approved for OUD treatment but is commonly used during medically supervised withdrawal as an adjunct or in settings where buprenorphine or methadone are not immediately available. COWS monitoring during clonidine treatment documents symptom response. Clonidine does not reduce opioid craving and has no evidence for preventing relapse, making it inferior to MOUD for long-term outcomes.

Common Questions About Your Results

Most induction protocols require COWS 8-12 or above before administering the first buprenorphine dose to ensure the patient is in sufficient withdrawal to prevent precipitated withdrawal. SAMHSA Treatment Improvement Protocol (TIP) 63 recommends COWS 8 or above as the minimum threshold for standard induction. Some clinicians use a higher threshold of COWS 12-16 for patients using fentanyl or long-acting opioids due to their prolonged receptor occupancy. Document the pre-induction COWS score in the medical record for every buprenorphine induction.

Administering buprenorphine when the patient still has significant full opioid agonists at receptors (typically COWS below 8) causes precipitated opioid withdrawal. Buprenorphine's high receptor affinity rapidly displaces the agonist, triggering immediate severe withdrawal within 15-30 minutes of dosing: intense muscle aches, severe restlessness, profuse sweating, nausea, vomiting, and extreme anxiety. Management of precipitated withdrawal is supportive — more buprenorphine (paradoxically, higher doses may alleviate it by achieving full receptor occupancy), benzodiazepines for anxiety, antiemetics, and IV fluids. Prevention through COWS-guided induction timing is far preferable.

Fentanyl's high lipophilicity and extensive tissue binding mean it is released slowly from fat stores for days to weeks after last use. This creates a situation where a patient may appear to be in relatively mild withdrawal (COWS 5-8) early after last dose, but receptor occupancy is still sufficient to cause precipitated withdrawal if buprenorphine is given. Standard heroin withdrawal peaks at 36-72 hours and resolves within 5-7 days; fentanyl withdrawal can have a prolonged course with persistent symptoms for 1-2 weeks. For fentanyl users, many clinicians recommend waiting for COWS 12-16 or using low-dose induction protocols.

No. COWS is specifically validated and calibrated for opioid withdrawal symptoms. The specific items (pupil dilation, gooseflesh, yawning, opioid-type GI symptoms) are characteristic of opioid withdrawal and are not applicable to benzodiazepine withdrawal. For alcohol withdrawal, use CIWA-Ar; for benzodiazepine withdrawal, clinical monitoring of anxiety, tremor, vital signs, and seizure risk guides management without a specific validated scale comparable to COWS or CIWA-Ar. Using COWS outside of opioid withdrawal will produce scores without clinical validity.

Evidence-Based Methodology

COWS published by Wesson and Ling (J Psychoactive Drugs 2003). COWS validated for opioid withdrawal severity and buprenorphine induction timing. Buprenorphine induction threshold COWS 8-12: SAMHSA TIP 63 (2021). Precipitated withdrawal mechanism and prevention: Bao et al. (Curr Psychiatry Rep 2021). DEA X-waiver removal: Mainstreaming Addiction Treatment (MAT) Act 2023. Low-dose buprenorphine induction: Herring et al. (Ann Emerg Med 2019). Extended-release naltrexone for OUD: Lee et al. (Lancet 2018).

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Higher COWS totals indicate more severe opioid withdrawal symptoms and support escalation of supervised withdrawal management intensity.

When to Use This Tool

Use in monitored opioid withdrawal settings to trend symptom burden and support treatment timing and reassessment decisions.

Limitations

Symptoms can overlap with anxiety, infection, stimulant effects, and other medical conditions, so the score should be interpreted within full clinical context.

For related assessments, see Opioid Risk Tool, Opioid MME and POSS Scale.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools

Mental Health

Opioid Risk Tool

Screen risk of opioid misuse with the Opioid Risk Tool before initiating long-term opioid therapy.

Open Pharmacy

Opioid MME

Calculate morphine milligram equivalents (MME) for opioid medications using CDC conversion factors. ≥50 MME/day warrants caution; ≥90 MME/day carries significantly increased overdose risk.

Open Pharmacy

POSS Scale

Classify opioid-related sedation severity (S, 1, 2, 3, 4) and map to common bedside action guidance.

Open

Frequently Asked Questions

The COWS (Clinical Opiate Withdrawal Scale) is an 11-item clinician-administered scale assessing opioid withdrawal severity through both observation (resting pulse, pupil size, sweating, tremor, yawning, gooseflesh) and patient report (restlessness, bone aches, runny nose, GI upset, anxiety). Total score ranges from 0 to approximately 48. It is the standard tool for monitoring opioid withdrawal and timing buprenorphine induction.

A minimum COWS score of 8-12 is typically required before administering the first buprenorphine dose, as confirmed by SAMHSA TIP 63 (2021). Below this threshold, patients still have significant opioid receptor occupancy, and buprenorphine can precipitate severe withdrawal. For fentanyl users, many clinicians require COWS 12-16 or use low-dose induction protocols due to fentanyl's prolonged tissue storage.

Precipitated withdrawal occurs when buprenorphine is given before the patient is in adequate withdrawal (COWS below 8). Buprenorphine's high mu-receptor affinity displaces full opioid agonists, immediately triggering severe withdrawal: intense muscle aches, profuse sweating, severe restlessness, nausea, vomiting, and anxiety within 15-30 minutes. It is not life-threatening but is extremely distressing and typically lasts several hours. Prevention by ensuring COWS threshold is met is the key safeguard.

Early opioid withdrawal (12-24 hours after last short-acting opioid dose): anxiety, restlessness, yawning, runny nose, tearing, mild sweating, insomnia. Peak withdrawal (36-72 hours): dilated pupils, severe muscle aches, gooseflesh, GI cramps, nausea, vomiting, diarrhea, tachycardia, hypertension, diaphoresis, severe craving. Fentanyl withdrawal may begin later and last longer. Opioid withdrawal is rarely life-threatening in otherwise healthy adults but is intensely uncomfortable.

COWS is for opioid withdrawal; CIWA-Ar is for alcohol withdrawal. They cannot be used interchangeably. Opioid withdrawal features include pupil dilation, gooseflesh, and rhinorrhea — not seen in alcohol withdrawal. Alcohol withdrawal features include tremor, autonomic hyperactivity, and hallucinations — scored differently from opioid symptoms. Both tools guide symptom-triggered treatment, but the specific symptoms, scoring systems, treatment medications, and medical risks differ completely between opioid and alcohol withdrawal.

Online Medical Tools — COWS Score

COWS Score

How It Works

Clinician Assesses 11 Objective and Subjective Withdrawal Items

Sum All Items to Produce Total Score (0-48)

Interpret Score to Guide Treatment — Especially Buprenorphine Induction Timing

Who Uses the COWS Score

Opioid Detoxification Inpatient Monitoring

Buprenorphine Induction Timing Assessment

Methadone Clinic Opioid Withdrawal Monitoring

Emergency Department Opioid Withdrawal Management

Opioid Use Disorder Research Endpoint

Suboxone Initiation in MOUD Programs

Pro Tips

Buprenorphine Induction Requires COWS 8-12 Minimum to Avoid Precipitated Withdrawal

Precipitated Withdrawal From Buprenorphine Is Severe and Distressing

Do Not Give Buprenorphine If COWS Is Below 8 — Wait for Adequate Withdrawal

Fentanyl Complicates Buprenorphine Induction Due to Prolonged Tissue Storage

Low-Dose Buprenorphine Induction (LDEI/Micro-Dosing) Circumvents Precipitated Withdrawal Risk

DEA X-Waiver Removed in 2023 — Any DEA-Registered Provider Can Prescribe Buprenorphine

Methadone Requires Daily Supervised Dosing at Licensed Opioid Treatment Programs

Clonidine Reduces Autonomic Withdrawal Symptoms But Is Not an OUD Treatment

Common Questions About Your Results

Evidence-Based Methodology

Clinical Content Trust

How to Interpret Your Result

When to Use This Tool

Limitations

Changelog

Related Tools

Opioid Risk Tool

Opioid MME

POSS Scale

Further Reading

Mental Health Screening Guide: Depression, Anxiety, Substance Use, and Cognitive Assessment

Frequently Asked Questions